Overview

A Study of Adebrelimab Combined With Chemoradiotherapy in the Treatment of Esophageal Small Cell Carcinoma

Status:
NOT_YET_RECRUITING
Trial end date:
2027-07-13
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy and safety of adebrelimab combined with chemoradiotherapy in the treatment of esophageal small cell carcinoma
Phase:
PHASE2
Details
Lead Sponsor:
Zhangzhou Municipal Hospital
Treatments:
Carboplatin
Cisplatin
Etoposide
Radiotherapy